Join the OxyContin group to help and get support from people like you.
OxyContin News (Page 2)
Most Patients Seen in Emergency Department for Pain Consume Few Opioids After Discharge
THURSDAY, Sept. 21, 2023 – Opioid prescriptions following emergency department discharge should be adapted to specific acute pain conditions, according to a study presented at the annual European...
Opioid-Free Discharge Feasible After Pancreatectomy
THURSDAY, Sept. 7, 2023 – Opioid-free discharge is feasible after pancreatic surgery, according to a study published online Sept. 6 in JAMA Surgery. Artem Boyev, D.O., from The University of Texas...
Counterfeit Pills Fuel Rising Number of Fatal Drug Overdoses
FRIDAY, Sept. 1, 2023 – A growing number of overdose deaths in the United States involve counterfeit pills, health officials reported Thursday. Overdose deaths involving counterfeit pills were twice...
1 in 10 ICU Patients With Heart Issues Has Illicit Drugs in Their System
FRIDAY, Aug. 18, 2023 – More than 1 out of every 10 patients who land in an ICU with a potentially deadly heart emergency test positive for recreational drug use, a new French study reports. About...
Prevalence of Recreational Drug Use 11 Percent in Cardiac ICUs
FRIDAY, Aug. 18, 2023 – For patients hospitalized in intensive cardiac care units (ICCUs), the prevalence of recreational drug use is 11 percent, according to a study published online Aug. 15 in...
Supreme Court Temporarily Blocks Oxycontin Maker's Bankruptcy Deal
FRIDAY, Aug. 11, 2023 – A bankruptcy deal that would have shielded the family behind the company that makes Oxycontin from civil lawsuits was temporarily blocked by the U.S. Supreme Court on...
Most People Initiating Opioid Rx Have Very Low Use Trajectory
MONDAY, Aug. 14, 2023 – Most adults initiating treatment with prescription opioids have relatively low and time-limited exposure to opioids during a five-year period, according to a study published...
Supreme Court Temporarily Blocks Oxycontin Maker's Bankruptcy Deal
FRIDAY, Aug. 11, 2023 – A bankruptcy deal that would have shielded the family behind the company that makes Oxycontin from civil lawsuits was temporarily blocked by the U.S. Supreme Court on T...
After U.S. Warns of Counterfeit Pills Laced With Fentanyl, Mexico Shuts Down 23 Pharmacies
WEDNESDAY, Aug. 9, 2023 – Following a four-day raid, Mexico has closed 23 pharmacies in Caribbean resorts of Cancun, Playa del Carmen, and Tulum for irregular pill sales. Last spring, the United...
After U.S. Warns of Counterfeit Pills Laced With Fentanyl, Mexico Shuts Down 23 Pharmacies
WEDNESDAY, Aug. 9, 2023 – Following a four-day raid, Mexico has closed 23 pharmacies in Caribbean resorts of Cancun, Playa del Carmen and Tulum for irregular pill sales. Last spring, the United...
Just 1 in 5 Americans Struggling With Opioid Misuse Gets Meds That Can Help
MONDAY, Aug. 7, 2023 – The U.S. opioid abuse epidemic wages on, and overdose deaths continue to rise, yet just 1 in 5 people receives potentially lifesaving medication such as methadone,...
Oxycodone Does Not Increase Risk for Persistent Opioid Use After Delivery
MONDAY, July 31, 2023 – Initiation of oxycodone versus codeine is not associated with an increased risk for persistent opioid use after delivery overall, but increased risk is seen after vaginal...
FDA Medwatch Alert: Drug Safety Communication: All Opioid Pain Medicines - FDA Updates Prescribing Information to Provide Additional Guidance for Safe Use
ISSUE: The FDA is requiring several updates to the prescribing information for both immediate-release (IR) and extended release/long acting (ER/LA) opioid pain medicines. This includes stating for a...
Narcan (naloxone HCl) Nasal Spray 2mg Approved by U.S. Food and Drug Administration
January 25, 2017 – Dublin, Ireland – Today, the U.S. Food and Drug Administration (FDA) approved Narcan Nasal Spray as a 2mg formulation for the emergency treatment of known or suspected opioid ove...
FDA Medwatch Alert: Opioid Pain or Cough Medicines Combined With Benzodiazepines: Drug Safety Communication - FDA Requiring New Boxed Warnings About Serious Risks and Death
ISSUE: FDA review has found that the growing combined use of opioid medicines with benzodiazepines or other drugs that depress the central nervous system (CNS) has resulted in serious side effects,...
Ask a question
To post your own question to this support group, sign in or create an account.